首页> 外文期刊>Biochemistry and Biophysics Reports >Crystal structure of 6aJL2-R24G light chain variable domain: Does crystal packing explain amyloid fibril formation?
【24h】

Crystal structure of 6aJL2-R24G light chain variable domain: Does crystal packing explain amyloid fibril formation?

机译:6aJL2-R24G轻链可变域的晶体结构:晶体堆积可以解释淀粉样蛋白原纤维的形成吗?

获取原文
       

摘要

Light chain amyloidosis is one of the most common systemic amyloidosis, characterized by the deposition of immunoglobulin light variable domain as insoluble amyloid fibrils in vital organs, leading to the death of patients. Germline λ6a is closely related with this disease and has been reported that 25% of proteins encoded by this germline have a change at position 24 where an Arg is replaced by a Gly (R24G). This germline variant reduces protein stability and increases the propensity to form amyloid fibrils. In this work, the crystal structure of 6aJL2-R24G has been determined to 2.0?? resolution by molecular replacement. Crystal belongs to space group I212121(PDB ID 5JPJ) and there are two molecules in the asymmetric unit. This 6aJL2-R24G structure as several related in PDB (PDB entries: 5C9K, 2W0K, 5IR3 and 1PW3) presents by crystal packing the formation of an octameric assembly in a helicoidal arrangement, which has been proposed as an important early stage in amyloid fibril aggregation. However, other structures of other protein variants in PDB (PDB entries: 3B5G, 3BDX, 2W0L, 1CD0 and 2CD0) do not make the octameric assembly, regardless their capacity to form fibersin vitroorin vivo. The analysis presented here shows that the ability to form the octameric assembly in a helicoidal arrangement in crystallized light chain immunoglobulin proteins is not required for amyloid fibril formationin vitro. In addition, the fundamental role of partially folded states in the amyloid fibril formationin vitro, is not described in any crystallographic structure published or analyzed here, being those structures, in any case examples of proteins in their native states. Those partially folded states have been recently described by cryo-EM studies, showing the necessity of structural changes in the variants before the amyloid fiber formation process starts.
机译:轻链淀粉样变性是最常见的系统性淀粉样变性之一,其特征在于免疫球蛋白轻可变域作为重要器官中的不溶性淀粉样原纤维沉积,导致患者死亡。胚系λ6a与该疾病密切相关,据报道,该种系编码的蛋白质中有25%的蛋白质在Arg被Gly(R24G)取代的24位发生变化。该种系变体降低了蛋白质的稳定性,并增加了形成淀粉样原纤维的倾向。在这项工作中,已确定6aJL2-R24G的晶体结构为2.0≤λ。通过分子替代解决。晶体属于空间群I212121(PDB ID 5JPJ),不对称单元中有两个分子。 PDB中几个相关的6aJL2-R24G结构(PDB条目:5C9K,2W0K,5IR3和1PW3)通过晶体堆积以螺旋状排列形式形成八聚体组装体,这已被认为是淀粉样原纤维聚集的重要早期阶段。 。但是,PDB中其他蛋白质变体的其他结构(PDB条目:3B5G,3BDX,2W0L,1CD0和2CD0)并不构成八聚体,无论它们在体外或体内形成纤维的能力如何。此处进行的分析表明,在体外淀粉样蛋白原纤维形成过程中,不需要在结晶的轻链免疫球蛋白中以螺旋状排列形成八聚体的能力。另外,在本文公开或分析的任何晶体结构中都没有描述部分折叠状态在体外淀粉样蛋白原纤维形成中的基本作用,即那些结构,在任何情况下均为天然状态的蛋白质实例。这些部分折叠的状态最近已通过cryo-EM研究进行了描述,表明淀粉样蛋白纤维形成过程开始之前,变体中必须进行结构改变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号